Correction to: Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020 (European Child & Adolescent Psychiatry, (2022), 10.1007/s00787-022-02034-2)

Anne Mette Skov Sørensen; Rikke Wesselhoeft; Jacob Harbo Andersen; Johan Reutfors; Carolyn E. Cesta; Kari Furu; Ingeborg Hartz; Lotte Rasmussen

doi:10.1007/s00787-022-02100-9

Correction to: Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020 (European Child & Adolescent Psychiatry, (2022), 10.1007/s00787-022-02034-2)

Anne Mette Skov Sørensen, Rikke Wesselhoeft, Jacob Harbo Andersen, Johan Reutfors, Carolyn E. Cesta, Kari Furu, Ingeborg Hartz, Lotte Rasmussen^*

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Abstrakt

The authors would like to correct the funding information on this article. The correct funding note should read: This work was financed by Project “PI17/00894”, funded by Instituto de Salud Carlos III and co-funded by European Union (ERDF), “A way to make Europe”.

Originalsprog	Engelsk
Tidsskrift	European Child and Adolescent Psychiatry
ISSN	1018-8827
DOI	https://doi.org/10.1007/s00787-022-02100-9
Status	E-pub ahead of print - 25. okt. 2022

Bibliografisk note

Publisher Copyright:
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2022.

Dokumenter og links

10.1007/s00787-022-02100-9

Fingeraftryk

Dyk ned i forskningsemnerne om 'Correction to: Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020 (European Child & Adolescent Psychiatry, (2022), 10.1007/s00787-022-02034-2)'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Sørensen, A. M. S., Wesselhoeft, R., Andersen, J. H., Reutfors, J., Cesta, C. E., Furu, K., Hartz, I., & Rasmussen, L. (2022). Correction to: Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020 (European Child & Adolescent Psychiatry, (2022), 10.1007/s00787-022-02034-2). European Child and Adolescent Psychiatry. https://doi.org/10.1007/s00787-022-02100-9

@article{8b891f7734c242be9f69dce4e978ba21,

title = "Correction to: Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020 (European Child & Adolescent Psychiatry, (2022), 10.1007/s00787-022-02034-2)",

abstract = "The authors would like to correct the funding information on this article. The correct funding note should read: This work was financed by Project “PI17/00894”, funded by Instituto de Salud Carlos III and co-funded by European Union (ERDF), “A way to make Europe”.",

author = "S{\o}rensen, {Anne Mette Skov} and Rikke Wesselhoeft and Andersen, {Jacob Harbo} and Johan Reutfors and Cesta, {Carolyn E.} and Kari Furu and Ingeborg Hartz and Lotte Rasmussen",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2022.",

year = "2022",

month = oct,

day = "25",

doi = "10.1007/s00787-022-02100-9",

language = "English",

journal = "European Child & Adolescent Psychiatry",

issn = "1018-8827",

publisher = "Springer",

}

Sørensen, AMS, Wesselhoeft, R , Andersen, JH, Reutfors, J, Cesta, CE, Furu, K, Hartz, I & Rasmussen, L 2022, 'Correction to: Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020 (European Child & Adolescent Psychiatry, (2022), 10.1007/s00787-022-02034-2)', European Child and Adolescent Psychiatry. https://doi.org/10.1007/s00787-022-02100-9

Correction to : Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020 (European Child & Adolescent Psychiatry, (2022), 10.1007/s00787-022-02034-2). / Sørensen, Anne Mette Skov; Wesselhoeft, Rikke ; Andersen, Jacob Harbo et al.

I: European Child and Adolescent Psychiatry, 25.10.2022.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

TY - JOUR

T1 - Correction to

T2 - Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020 (European Child & Adolescent Psychiatry, (2022), 10.1007/s00787-022-02034-2)

AU - Sørensen, Anne Mette Skov

AU - Wesselhoeft, Rikke

AU - Andersen, Jacob Harbo

AU - Reutfors, Johan

AU - Cesta, Carolyn E.

AU - Furu, Kari

AU - Hartz, Ingeborg

AU - Rasmussen, Lotte

PY - 2022/10/25

Y1 - 2022/10/25

N2 - The authors would like to correct the funding information on this article. The correct funding note should read: This work was financed by Project “PI17/00894”, funded by Instituto de Salud Carlos III and co-funded by European Union (ERDF), “A way to make Europe”.

AB - The authors would like to correct the funding information on this article. The correct funding note should read: This work was financed by Project “PI17/00894”, funded by Instituto de Salud Carlos III and co-funded by European Union (ERDF), “A way to make Europe”.

U2 - 10.1007/s00787-022-02100-9

DO - 10.1007/s00787-022-02100-9

M3 - Comment/debate

C2 - 36280601

AN - SCOPUS:85140442317

SN - 1018-8827

JO - European Child & Adolescent Psychiatry

JF - European Child & Adolescent Psychiatry

ER -

Sørensen AMS, Wesselhoeft R , Andersen JH, Reutfors J, Cesta CE, Furu K et al. Correction to: Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020 (European Child & Adolescent Psychiatry, (2022), 10.1007/s00787-022-02034-2). European Child and Adolescent Psychiatry. 2022 okt. 25. Epub 2022 okt. 25. doi: 10.1007/s00787-022-02100-9